Connection

Thomas Efferth to Treatment Outcome

Back to Details
This is a "connection" page, showing publications Thomas Efferth has written about Treatment Outcome.
Thomas Efferth
Connection Strength
0.020
Treatment Outcome
  1. Long-term add-on therapy (compassionate use) with oral artesunate in patients with metastatic breast cancer after participating in a phase I study (ARTIC M33/2). Phytomedicine. 2019 Feb 15; 54:140-148.
    View in: PubMed
    Score: 0.007
  2. Chemoresistance and chemosensitization in cholangiocarcinoma. Biochim Biophys Acta Mol Basis Dis. 2018 04; 1864(4 Pt B):1444-1453.
    View in: PubMed
    Score: 0.006
  3. Prospective open uncontrolled phase I study to define a well-tolerated dose of oral artesunate as add-on therapy in patients with metastatic breast cancer (ARTIC M33/2). Breast Cancer Res Treat. 2017 Jul; 164(2):359-369.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.